Twist Biosciences, Inc. (NASDAQ: TWST) manufactures and sells synthetic DNA-based products by leveraging the Company’s DNA synthesis platform that helps write DNA on a silicon chip. The Company offers products such as synthetic genes, sample preparation tools, antibody libraries for drug discovery and development, and...
Collaboration Agreement with Sanofi IGM Biosciences, Inc. (NASDAQ: IGMS), a biotechnology company leveraging its expertise in Immunoglobulin M (IgM) antibodies, announced an exclusive worldwide collaboration agreement with Sanofi (NASDAQ: SNY). The agreement is for developing and commercializing IgM antibody agonists against six initial targets, three in...
Immunome, Inc. (NASDAQ: IMNM), a biopharmaceutical company developing novel first-in-class antibody therapeutics targeting oncology and infectious diseases, announced the receipt of a clinical hold letter from the U.S. Food and Drug Administration (FDA) for its recently submitted Investigational New Drug (IND) for IMM-BCP-01, a three-antibody...
The Global Stock markets are currently facing the fallout from wide-spread pandemonium owing to the coronavirus scare. The outbreak has affected trade and services across the globe, with companies having to step back and access the full impact of the situation. However there are some...
Inovio Pharmaceuticals (NASDAQ: INO), a late-stage biotechnology Company developing DNA-based immunotherapies and vaccines to combat cancer and infectious diseases, announced the grant of up to $9 million by the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for Coronavirus 2019-nCoV, a deadly new...
Crohn’s is an inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract, chronic diarrhea, abdominal cramps, rectal bleeding and constipation to name a few. It is estimated that Crohn’s disease affects 780,000 Americans, with the highest prevalence being between the ages of 15...
